Deltex Medical has earned a recommendation from the National Institute for Health and Clinical Excellence (NICE) for its CardioQ-ODM oesophageal Doppler monitor.
The UK regulator has issued guidance that endorses the technology for use in major and high-risk surgery, with estimates suggesting that its widespread use could save the NHS 880 million pounds a year.
Deltex's device uses a disposable ultrasound probe placed in the oesophagus to measure blood flow in the central circulation, allowing clinicians to deliver fluid guided management in patient recovery.
This facilitates the post-surgical healing process and helps patients to leave hospital earlier and in a better condition, which also allows medical facilities to save money.
Ewan Phillips, Deltex's chief executive, said: "NICE's final guidance is a resounding endorsement for the CardioQ-ODM at a time when the NHS is charged with delivering 20 billion pounds of efficiency savings over the next three years."
The CardioQ-ODM was researched and designed at the firm's UK base and has been used to benefit more than 400,000 patients to date.See all the latest jobs in Medical Devices